Oesophageal ulceration after selective internal radiation therapy in a patient with carcinoma of unknown primary

Zeitschrift fur Gastroenterologie

Volumn 48, Issue 5, 2010, Pages 546-550

  Kubisch, Constanze Heike ^a   Beigel, F ^a   Ihrler, S ^a   Goke, B ^a   Reiser, M F ^b   Hoffmann, R T ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

CUP; Gastroenteropancreatic tumors; Liver; SIRT

Indexed keywords

ANTINEOPLASTIC AGENT; MICROSPHERE;

ADVERSE OUTCOME; ARTICLE; AWARENESS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER OF UNKNOWN PRIMARY SITE; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL EVALUATION; DISEASE CONTROL; DUODENUM ULCER; ESOPHAGUS ULCER; HEMIHEPATECTOMY; HUMAN; LIVER CANCER; MULTIMODALITY CANCER THERAPY; QUALITY OF LIFE; SELECTIVE INTERNAL RADIATION THERAPY; STOMACH ULCER; TUMOR BIOPSY; ADENOCARCINOMA; ADJUVANT THERAPY; ARTIFICIAL EMBOLISM; BRACHYTHERAPY; DIGESTIVE TRACT ENDOSCOPY; DISEASE COURSE; DUODENUM; ESOPHAGUS; ESOPHAGUS DISEASE; FEMALE; INTESTINE MUCOSA; LIVER RESECTION; LIVER TUMOR; METASTASIS; MIDDLE AGED; PATHOLOGY; RADIATION EXPOSURE; RADIATION INJURY; STOMACH MUCOSA; ULCER; VASCULARIZATION;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRACHYTHERAPY; DISEASE PROGRESSION; DUODENAL ULCER; DUODENUM; EMBOLIZATION, THERAPEUTIC; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL DISEASES; ESOPHAGUS; FEMALE; GASTRIC MUCOSA; HEPATECTOMY; HUMANS; INTESTINAL MUCOSA; LIVER NEOPLASMS; MICROSPHERES; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASMS, UNKNOWN PRIMARY; RADIATION INJURIES; RADIOTHERAPY, ADJUVANT; STOMACH ULCER; ULCER;

EID: 77954152318     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1109694     Document Type: Article

References (23)

1. Pavlidis N, Fizazi K. Cancer of unknown primary (cup). Crit Rev Oncol Hematol 2005; 54: 243-250
2. Pavlidis N, Briasoulis E, Hainsworth J et al. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003; 39: 1990-2005 (Pubitemid 37297755)
3. Le Chevalier T, Cvitkovic E, Caille P et al. Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients. Arch Intern Med 1988; 148: 2035-2039
4. Nystrom JS, Weiner JM, Heffelfinger-Juttner J et al. Metastatic and histologic presentations in unknown primary cancer. Semin Oncol 1977; 4: 53-58
5. Kolesnikov-Gauthier H, Levy E, Merlet P et al. FDG PET in patients with cancer of an unknown primary. Nucl Med Commun 2005; 26: 1059-1066
6. Mousseau M, Schaerer R, Lutz JM et al. Hepatic metastasis of unknown primary site. Bull Cancer 1991; 78: 725-736
7. Pentheroudakis G, Briasoulis E, Pavlidis N. Cancer of unknown primary site: Missing primary or missing biology? Oncologist 2007; 12: 418-425
8. Briasoulis E, Pavlidis N. Cancer of unknown primary origin. Oncologist 1997; 2: 142-152
9. Greco FA, Pavlidis N. Treatment for patients with unknown primary carcinoma and unfavorable prognostic factors. Semin Oncol 2009; 36: 65-74
10. Huebner G, Link H, Kohne CH et al. Paclitaxel and carboplatin vs. gemcitabine and vinorelbine in patients with adeno- or undifferentiated carcinoma of unknown primary: A randomised prospective phase ii trial. Br J Cancer 2009; 100: 44-49
11. Lazaridis G, Pentheroudakis G, Fountzilas G et al. Liver metastases from cancer of unknown primary (cupl): A retrospective analysis of presentation, management, and prognosis in 49 patients and systematic review of the literature. Cancer Treat Rev 2008; 34: 693-700
12. Greco FA, Hainsworth JD. Introduction: Unknown primary cancer. Semin Oncol 2009; 36: 6-7
13. Kennedy A, Nag S, Salem R et al. Recommendations for radioembolization of hepatic malignancies using yttrium-90 microsphere brachytherapy: A consensus panel report from the radioembolization brachytherapy oncology consortium. Int J Radiat Oncol Biol Phys 2007; 68: 13-23
14. Van Hazel G, Blackwell A, Anderson J et al. Randomised phase 2 trial of sir-spheres plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 2004; 88: 78-85 (Pubitemid 39536508)
15. Lau WY, Ho S, Leung TW et al. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres. Int J Radiat Oncol Biol Phys 1998; 40: 583-592 (Pubitemid 28104228)
16. Jakobs TF, Hoffmann RT, Poepperl G et al. Mid-term results in otherwise treatment refractory primary or secondary liver confined tumors treated with selective internal radiation therapy (sirt) using (90)yttrium resin-microspheres. Eur Radiol 2007; 17: 1320-1330
17. Stubbs RS, Cannan RJ, Mitchell AW. Selective internal radiation therapy (sirt) with 90yttrium microspheres for extensive colorectal liver metastases. Hepatogastroenterology 2001; 48: 333-337 (Pubitemid 32391561)
18. Lau WY, Leung WT, Ho S et al. Treatment of inoperable hepatocellular carcinoma with intrahepatic arterial yttrium-90 microspheres: A phase i and ii study. Br J Cancer 1994; 70: 994-999
19. Ogawa F, Mino-Kenudson M, Shimizu M et al. Gastroduodenitis associated with yttrium 90-microsphere selective internal radiation: An iatrogenic complication in need of recognition. Arch Pathol Lab Med 2008; 132: 1734-1738
20. Mallach S, Ramp U, Erhardt A et al. An uncommon cause of gastro-duodenal ulceration. World J Gastroenterol 2008; 14: 2593-2595 (Pubitemid 352037754)
21. Atassi B, Bangash AK, Lewandowski RJ et al. Biliary sequelae following radioembolization with yttrium-90 microspheres. J Vasc Interv Radiol 2008; 19: 691-697
22. Leung TW, Lau WY, Ho SK et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phy 1995; 33: 919-924
23. Kennedy AS, McNeillie P, Dezarn WA et al. Treatment parameters and outcome in 680 treatments of internal radiation with resin (90) Y-microspheres for unresectable hepatic tumors. Int J Radiat Oncol Biol Phys 2009; 74: 1494-1500